Myeloproliferative Neoplasms Clinical Trial

A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Myelofibrosis Through Chart Review

Summary

Myelofibrosis (MF) is a rare blood cancer, characterized by extensive fibrosis (scarring) of the bone marrow. It is one of a group of cancers known as myeloproliferative neoplasms (MPNs) in which bone marrow cells that produce blood cells develop and function abnormally. This study will evaluate treatment patterns, treatment outcomes, healthcare resource utilization in adult participants with Myelofibrosis.

Data from approximately 1000 participants will be collected. No participants will be enrolled in this study.

Participants' charts will be reviewed. No drug will be administered as a part of this study. The duration of the observation period is up to 156 weeks.

There is no additional burden for participants in this trial. All visits must be completed prior to data extraction and participants will be followed for up to 156 weeks.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Treated for myelofibrosis (MF) [primary myelofibrosis (PMF) and secondary myelofibrosis (SMF)].
Must have initiated their first treatment on or after the first date when ruxolitinib was approved in their country of residence and no later than 31 December 2021.

Exclusion Criteria:

- Having received MF treatment in a clinical trial setting.

Study is for people with:

Myeloproliferative Neoplasms

Estimated Enrollment:

998

Study ID:

NCT05444972

Recruitment Status:

Completed

Sponsor:

AbbVie

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 65 Locations for this study

See Locations Near You

UAB Comprehensive Cancer Center /ID# 252767
Birmingham Alabama, 35233, United States
Wellness Oncology & Hematology /ID# 255591
West Hills California, 91307, United States
Brigham & Women's Hospital /ID# 254312
Boston Massachusetts, 02115, United States
Gabrail Cancer Center Research /ID# 252768
Canton Ohio, 44718, United States
Instituto FIDES /ID# 245526
La Plata Buenos Aires, 1900, Argentina
Hospital Italiano de Buenos Aires /ID# 244373
Ciudad Autonoma Buenos Aires Ciuadad Autonoma De Buenos Aires, 1199, Argentina
Fundaleu /Id# 244371
Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires, 1114, Argentina
Townsville University Hospital /ID# 246585
Douglas Queensland, 4814, Australia
Royal Adelaide Hospital /ID# 246583
Adelaide South Australia, 5000, Australia
Fiona Stanley Hospital /ID# 246584
Murdoch Western Australia, 6150, Australia
Royal Perth Hospital /ID# 246586
Perth Western Australia, 6000, Australia
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein /ID# 247394
São Paulo Sao Paulo, 05652, Brazil
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo /ID# 247392
Sao Paulo , 05403, Brazil
St. Paul's Hospital /ID# 249719
Vancouver British Columbia, V6Z 1, Canada
Nova Scotia Health /ID# 248393
Halifax Nova Scotia, B3H 1, Canada
Juravinski Cancer Centre /ID# 251334
Hamilton Ontario, L8V 1, Canada
Princess Margaret Cancer Centre /ID# 249748
Toronto Ontario, M5G 2, Canada
CSSS Alphonse-Desjardins, CHAU de Levis /ID# 250449
Levis Quebec, G6V 3, Canada
CIUSSS de l'est de l'Ile-de-Montreal - Hopital Maisonneuve-Rosemont /ID# 250563
Montreal Quebec, H1T 2, Canada
Jewish General Hospital /ID# 250674
Montreal Quebec, H3T 1, Canada
Organizacion Clinica Bonnadona -PREVENIR S.A.S. /ID# 244589
Baranquilla Atlantico, 08001, Colombia
Coorp Hosp Juan Ciudad Sede Hospital Universitario Mayor Mederi /ID# 246108
Bogota DC Cundinamarca, 11122, Colombia
Fundacion Santa Fe de Bogota /ID# 244588
Bogota Cundinamarca, 11011, Colombia
Clínica Imbanaco S.A.S /ID# 248465
Cali , 76004, Colombia
Hospital Pablo Tobon Uribe /ID# 244525
Medellin , 50034, Colombia
General Hospital of Athens Laiko /ID# 246159
Athens Attiki, 11527, Greece
University General Hospital Attikon /ID# 246167
Athens Attiki, 12462, Greece
University General Hospital of Heraklion PA.G.N.I /ID# 246163
Heraklion Kriti, 71500, Greece
General University Hospital of Alexandroupolis /ID# 246161
Alexandroupolis , 68100, Greece
General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 246165
Athens , 10676, Greece
University General Hospital of Ioannina /ID# 246160
Ioannina , 45500, Greece
METAXA Cancer Hospital of Piraeus /ID# 246164
Piraeus , 18737, Greece
University General Hospital of Patras /ID# 246162
RION Patras Achaia , 26504, Greece
Azienda Ospedaliero-Universitaria di Ferrara-Arcispedale Sant Anna /ID# 245149
Cona Ferrara, 44124, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 245335
Rome Lazio, 00168, Italy
Azienda Ospedaliera di Perugia /ID# 245415
Perugia Umbria, 06129, Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna /ID# 245716
Bologna , 40138, Italy
ASST Spedali civili di Brescia /ID# 244910
Brescia , 25123, Italy
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 244909
Milan , 20122, Italy
Azienda Ospedaliero Universitaria Maggiore della Carita di Novara /ID# 245566
Novara , 28100, Italy
Azienda Ospedaliera Universitaria Paolo Giaccone /ID# 245075
Palermo , 90127, Italy
ASST Sette Laghi /ID# 245443
Varese , 21100, Italy
Ospedale Belcolle /ID# 245726
Viterbo , 01100, Italy
Hospital de Especialidades CMN SigloXXI /ID# 244748
Ciudad de México Ciudad De Mexico, 06720, Mexico
Centro Regiomontano de Estudios Clínicos ROMA S.C /ID# 244750
Monterrey Nuevo Leon, 64610, Mexico
Hospital General de Mexico /ID# 244749
Ciudad de Mexico , 06720, Mexico
Krzysztof Mądry Praktyka Lekarska /ID# 250485
Warsaw Mazowieckie, 01-30, Poland
Specjalistyczna Praktyka Lekarska Witold Prejzner /ID# 250516
Gdańsk Pomorskie, 80-33, Poland
Specjalistyczna Praktyka Lekarska Grzegorz Helbig /ID# 250515
Orzesze , 43-18, Poland
Joanna Góra-Tybor Specjalistyczna Praktyka Lekarska /ID# 250495
Łódź , 90-71, Poland
Centro Hospitalar e Universitario de Coimbra, EPE /ID# 244687
Coimbra , 3000-, Portugal
Centro Hospitalar Universitario de Lisboa Norte, EPE - Hospital de Santa Maria /ID# 248203
Lisboa , 1649-, Portugal
Centro Hospitalar Universitario de Sao Joao, EPE /ID# 244400
Porto , 4200-, Portugal
MedLife - Policlinica de Diagnostic Rapid /ID# 244395
Brașov Brasov, 50015, Romania
Institutul Clinic Fundeni /ID# 245939
Bucharest , 92520, Romania
Spitalul Clinic Colentina /ID# 245620
Bucuresti , 02012, Romania
Institutul Oncologic Prof Dr I Chiricuta /ID# 244393
Cluj Napoca , 40001, Romania
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 250092
Kaohsiung , 807, Taiwan
National Taiwan University Hospital /ID# 250093
Taipei City , 100, Taiwan
Gulhane Askeri Tip Academy /ID# 244134
Ankara , 06010, Turkey
Hacettepe University Medical Faculty /ID# 244131
Ankara , 06230, Turkey
Dicle Universitesi Tip /ID# 244137
Diyarbakir , 21200, Turkey
Trakya University Medical Facu /ID# 244132
Edirne, Istanbul , 22030, Turkey
Bagcilar Medipol Mega Universite Hastanesi /ID# 244133
Istanbul , 34214, Turkey
Ege University Medical Faculty /ID# 244130
Izmir , 35040, Turkey
Inonu University Medical Faculty /ID# 244135
Malatya , 44280, Turkey

How clear is this clinincal trial information?

Study is for people with:

Myeloproliferative Neoplasms

Estimated Enrollment:

998

Study ID:

NCT05444972

Recruitment Status:

Completed

Sponsor:


AbbVie

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.